CLINICAL_TRIALS
trial_result
· 2022-04-28
Clinical Trial Update: ICI-VPH: Impact of HPV Immunisation Schedules Against HPV [Phase 3]
Summary
Phase 3 trial update on the impact of HPV vaccination schedules on outcomes related to Human Papillomavirus infections.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: CHU de Quebec-Universite Laval | Conditions: Human Papillomavirus Infections | Phase 3 | Status: COMPLETED